Влияние петлевых диуретиков торасемида и фуросемида на клиническое течение, диастолическую функцию левого желудочка и биохимические маркеры баланса коллагена у больных с компенсированной сердечной нед
Диссертация
Впервые проведена комплексная оценка состояния гемодинамики, уровня мозгового натрийуретического пептида и биохимических маркеров баланса коллагена у больных с ХСН, протекающей на фоне высокого ДН ЛЖ, но без клинических признаков задержки жидкости в организме. Впервые для этой категории больных было показано, что рост тяжести их сердечной недостаточности ассоциирован со смещением баланса… Читать ещё >
Список литературы
- Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failure. JAMA. 2002- 287(5):628−40.
- Francis G S, Tang WHW, Sonnenblick E. Patophysiology of heart failure. In: Valentin F, ed. Hurst’s the heart, 11th ed. New York: McGraw-Hill, 2003.
- Patterson JH, Adams KF Jr., Applefeld MM, et al., for the Torasemide Investigators Group. Oral torasemide in patients with chronic congestive heart failure: effects on body weight, edema, and electrolyte excretion. Pharmacotherapy. 1994- 14:514 -21.
- Sherman LG, Liang CS, Baumgardner S, et al. Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure. Clin Pharmacol Ther. 1986−40:587−94.
- Brater DC. Diuretic therapy. N Engl J Med. 1998- 339(6):387−95.
- Wilson JR, Reichek N, Dunkman WB, et al. Effect of diuresis on the performance of the failing left ventricle in man. Am J Med. 1981−70:234−9.
- Richardson A, Bayliss J, Scriven AJ, et al. Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure.Lancet. 1987−2:709 -11.
- Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989/261. 884−888
- Chomsky DB, Lang CC, Rayos G, Wilson JR. Treatment of subclinical fluid retention in patients with symptomatic heart failure: effect on exercise performance. J Heart Lung Transplant. 1997−16:846−853.
- Drazner MH, Hamilton MA, Fonarow G, et al. Relationship between right and left-sided filling pressures in 1000 patients withadvanced heart failure. J Heart Lung Transplant. 1999- 18:1126−1132.
- Rivas-Gotz C., Manolios M., Thohan V., et al. Impact of left ventricular ejection fraction on estimation of left ventricular filling pressures using tissue Doppler and flow propagation velocity. Am J Cardiol 2003- 91:780—4.
- Nagueh S., Middleton K., Kopelen H., et al. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997- 30:1527—33.
- Nagueh S., Lakkis N., Middleton K., et al. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 1999- 99:254—61.
- Ishikura F., Redfield M. Doppler echocardiography assessment of diastolic function in congestive heart failure: emphasis on clinical utility. Heart failure 1998- 14:78—96.
- Овчинников А.Г., Агеев Ф. Т. Ультразвуковое исследование в оценке диастолического давления в левом желудочке. Журнал Сердечная недостаточность 2009- Т. 10- 4 (54): 221−236.
- Diez J., Laviades С., Mayor G et al. Increased serum concentrations of procollagen peptides in essential hypertension: relation to cardiac alterations. Circulation 1995−91:1450—6.
- Diez J., Panizo A., Gil M. et al. Serum markers of collagen type 1 metabolism in spontaneously hypertensive rates: relation to myocardial fibrosis. Circulation 1996−93:1026—32.
- Uchida T, Yamanaga K, Nishikawa M, et al. Anti-aldosteronergic effect of torasemide. Eur J Pharmacol. 1991- 205(2): 145−50.
- Uchida Т., Yamanaga K., Kido H., et al. Diuretic and vasodilating actions of torasemide. Cardiology. 1994- 84 Suppl 2:14−7.
- Goodfriend T.L., Ball D.L., Oelkers W., Bahr V. Torsemide inhibits aldosterone secretion in vitro. Life Sci. 1998−63(3):PL45−50.
- Tanaka H., Watanabe K., Harima M., et al. Effects of various diuretics on cardiac function in rats with heart failure. Yakugaku Zasshi. 2009- 129(7):871−9.
- Veeraveedu P.T., Watanabe К., Ma M., et al. Comparative effects of torasemide and fiirosemide in rats with heart failure. Biochem Pharmacol. 2008- 75(3):649−59.
- Tsutamoto T, Sakai H, Wada A, et al. Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure. J Am Coll Cardiol. 2004- 44(11):2252−3.
- Lopez В, Querejeta R, Gonzalez A, et al. Effects of loop diuretics on myocardial fibrosis and collagen type 1 turnover in chronic heart failure. J Am Coll Cardiol. 2004- 43(11):2028−35.
- Abhayaratna W P, Marwick T H, Smith W T, Becker N G Characteristics of left ventricular diastolic dysfunction in the community: an echocardiography survey. Heart 2006- 92:1259−1264.
- Little W.C., Downes T.R. Clinical evaluation of left ventricular diastolic performance. Prog Cardiovasc Dis 1990- 32:273−90.
- Bonow RO, Udelson J E. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Ann Intern Med. 1992- 117:502−510.
- Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician’s Rosetta Stone. J Am Coll Cardiol. 1997- 30:8−18.
- Dokainish H., Zoghbi W., Lakkis N., et al. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 2005−45:1223−6.
- Redfield M., Jacobsen S., Burnett J., et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003- 289:194—202.
- Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic fiinction.Circulation.2002 19- 105(11):1387−93.
- Rahimtoola S., Loeb H., Ehsani A., et al. Relationship of pulmonary artery to left ventricular diastolicpressures in acute myocardial infarction. Circulation 1972- 46:283—90.
- Penpargkul S., Repke D., Katz A., et al. Effect of physical training on calcium transport by rat cardiac sarcoplasmic reticulum. Circ Res 1977- 40:134—8.
- Labeit S., Kolmerer B., Linke W. The giant protein titin: emerging roles in physiology and pathophysiology. Cir Res 1997−80:290−4.
- Gilbert J.C., Glantz S.A. Determinants of left ventricular filling and of the diastolic presse-volume relation. Circ Res 1989−64:827−52.
- Glantz S.A., Parmley W.W. Factors which affect the diastolic presse-volume curve. Circ Res 1978- 42(2) 171−80
- Ishida Y., Meisner J., Tsujioka K., et al. Left ventricular filling dynamics: influence of left ventricular relaxation and left atrial pressure. Circulation 1986- 74:187—96.
- Gardin J., Dabestini A., Takenaka K., et al. Effect of imaging view and sample volume location on evaluation of mitral flow velocity by pulsed Doppler echocardiography. Am J Cardiol 1986- 57:1335—9.
- Villari B., Campbell S., Hess O., et al. Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease. J Am Coll Cardiol 1993- 22:1477—84.
- Chapman D., Weber K., Eghbali M. Reguation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in hypertrophied rat myocardium. Circ Res 1990- 67:787—94.
- Weber K., Janicki J., Schroff S., et al. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res 1988- 62:757—65.
- Weber K., Brilla C. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991- 83:1849—65.
- Weber K., Sun Y., Campbell S. Structural remodeling of the heart by fibrous tissue: Role of circulating hormones and locally produced peptides. Eur Heart J 1995- 16(Suppl N): 12—8.
- Appleton C., Hatle L., Popp R. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 1988- 12:426-^0.
- Spinale F. Matrix mettaloproteinases: regulation and dysregulation in the failing heart. Circ Res 2002- 890:520—30.
- Spinale F., Coker M., Bond B., Zellner J. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target. Cardiovasc Res 2000- 46:225—38.
- Sawyer D., Colucci W.: Molecular and cellular events in myocardial hypertrophy and failure. In Colucci WS ed.: Atlas of Heart Failure: Cardiac Function and Dysfunction. 3rd ed. Philadelphia, Current Medicine, 2002, p 7.8.
- Woessner J. Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991−131:2145−54.
- Redfield M. Understanding «diastolic» heart failure. N Engl J Med 2004−350:1930—1.
- Nagueh S., Appleton C., Gillebert T., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009−22:107—33
- Thomas J., Weyman A. Echocardiographic Doppler evaluation of left ventricular diastolic function: Physics and physiology. Circulation 1991- 84:977—90.
- Klein A., Hatle L., Taliercio C., et al. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis: a Doppler echocardiography study. Circulation 1991- 83:808—16.
- Shen WF., Tribouilloy C., Rey J-L., et al. Prognostic significance of Doppler-derived left ventricular diastolic filling variables in dilated cardiomyopathy. Am Heart J, 124 (1992) — 1524−1533.
- Werner GS, Schaefer C, Dirks R, et al. Prognostic value of Doppler echocardiographic assessment of left ventricular filling in idiopathic dilated cardiomyopathy. Am J Cardiol, 73 (1994) — 792−798.
- Xie G., Berk M., Smith M., et al. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol 1994- 24:132—9.
- Pinamonti B, Zecchin M, Di Lenarda A, et al. Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. J Am Coll Cardiol. 1997−29(3):604−12.
- Klein A., Burstow D., Tajik A., et al. Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons. Mayo Clin Proc, 69 (1994) — 212−224.
- Little W., Ohno M., Kitzman D., et al. Determination of left chamber stiffness from the time for deceleration of early left ventricular filling. Circulation 1995- 92:1933—9.
- Appleton C., Hatle L. The natural history of left ventricular filling abnormalities: assessment by two-dimensional and Doppler echocardiography. Echocardiography 1992- 9:437—57.
- Nishimura R., Abel M., Hatle L., et al. Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography. Part II: clinical studies. Mayo Clin Proc 1989−64:181—204.
- Rossvoll O., Hatle L. Pulmonary venous flow velocity recorded by transthoracic Doppler ultrasound: relation to left ventricular diastolic pressures. J Am Coll Cardiol 1993- 21:1687—96.
- Klein A., Abdalla I., Murray R., et al. Age independence of the difference in duration of pulmonary venous atrial reversal flow and transmitral A-wave flow in normal subjects. J Am Soc Echocardiogr 1998- 11:458—65.
- Shan K., Bick R., Poindexter B., et al. Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrenergic receptor density in humans. J Am Coll Cardiol 2000- 36:891—6.
- Sohn D., Chai I., Lee D., et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997- 30:474—80.
- Nagueh S., Sun H., Kopelen H., et al. Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J Am Coll Cardiol 2001- 37:278—85.
- Firstenberg M., Greenberg N., Main M., et al. Determinants of diastolic myocardial tissue Doppler velocities: influences of relaxation and preload. J Appl Physiol 2001- 90:299—307.
- Nagueh S., Mikati I., Kopelen H., et al. Doppler estimation of left ventricular filling pressure in sinus tachycardia: a new application of tissue Doppler imaging. Circulation 1998- 98:1644—50.
- Nagueh S., Kopelen H., Quifiones M. Assessment of left ventricular filling pressures by Doppler in the presence of atrial fibrillation. Circulation 1996- 94:2138—45.
- Brun P., Tribouilly C., Duval A., et al. Left ventricular flow propagation during early filling is related to wall relaxation: a color M-mode Doppler analysis. J Am Coll Cardiol 1992- 20:420—32.
- Stugaard M., Smiseth O., Risoe C., et al. Intraventricular early diastolic filling during acute myocardial ischemia, assessment by multigated color M-mode Doppler echocardiography. Circulation 1993- 88:2705—13.
- Garcia M., Ares M., Asher C., et al. An index of early left ventricular filling that combined with pulsed Doppler peak E velocity may estimate capillary wedge pressure. J Am Coll Cardiol 1997- 29:448—54.
- Hasegawa H., Little W., Ohno M., et al. Diastolic mitral annular velocity during the development of heart failure. J Am Coll Cardiol 2003- 41:1590—7.
- Tsang T., Barnes M., Gersh B., et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002- 90:1284— 9.
- Pritchett AM, Mahoney DW, Jacobsen SJ, et al. Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol. 2005- 45(l):87−92.
- Tsang T., Gersh B., Appleton C et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002- 40:1 636 164
- Shin S., Lim H., Choi U., et al. Impaired transport function of the left atrium in patients with lone paroxysmal atrial fibrillation. Echocardiography 2011- 28:44—51.
- Prioli A., Marino P., Lanzoni L., Zardini P. Increasing degrees of left ventricular filling impairment modulate left atrial functions in humans. Am J Cardiol 1998- 82:756−61.
- Manning WJ, Silverman DI, Katz SE, Douglas PS. Atrial ejection force: a noninvasive assessment of atrial systolic function. J Am Coll Cardiol 1993- 22:221−5.
- Stefanadis C, Dernellis J, Lambrou S, Toutouzas P. Left atrial energy in normal subjects, in patients with symptomatic mitral stenosis, and in patients with advanced heart failure. Am J Cardiol 1998- 82:1220—3.
- Enriquez-Sarano M, Rossi A, Seward JB, et al. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol 1997- 29: 153−9.
- Capomolla S, Febo O, Guazzotti G, et al. Invasive and non-invasive determinants of pulmonary hypertension in patients with chronic heart failure. J Heart Lung Transplant 2000- 19: 426−38.
- Bouchard JL, Aurigemma GP, Hill JC, et al. Usefulness of the pulmonary arterial systolic pressure to predict pulmonary arterial wedge pressure in patients with normal left ventricular systolic function. Am J Cardiol 2008−101:1673−6.
- Pozzoli M., Traversi E., Cioffi G., et al. Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure. Circulation 1997- 95:1222—30.
- Appleton C., Firstenberg M., Garsia M., Thomas J. The echo-Doppler evaluation of left ventricular diastolic function: a current perspective. Cardiol Clin 2003- 18(ix):513—46.
- Dumesnil J., Gaudreault Q, Honos Q, et al. Use of Valsalva maneuver to unmask left ventricular diastolic function abnormalities by Doppler echocardiography in patients with coronary artery disease or systemic hypertension. Am J Cardiol 1991−68:515−19.
- Temporelli P., Corra U., Imparato A., et al. Reversible restrictive left ventricular diastolic filling with optimized oral therapy predicts a more favorable prognosis in patients with chronic heart failure. J Am Coll Cardiol 1998−31:1591−7.
- Brunazzi M, Chirillo F, Pasqualini M et al. Estimation of left ventricular diastolic pressures from precordial pulsed-Doppler analysis of pulmonary venous and mitral flow. Am Heart J. 1994- 128:293−300.
- Chenzbraun A, Keren A., Stern S. Doppler echocardiographic patterns of left ventricular filling in patients early after acute myocardial infarction. Am J Cardiol 1992- 70:711−714.
- Kinnunen P, Vuolteenaho O, Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology 1993- 132:1961−70.
- Troughton R., Prior D., Pereira J., et al. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 2004−43:416−22.
- Mariano-Goulart D., Eberle M., Boudousq V., et al. Major increase in brain natriuretic peptide indicatesright ventricular systolic dysfunction in patients with heart failure. Eur J Heart Fail 2003−5:481—8.
- Hunt J., Yandle T., Nicholls M., et al. The amino-terminal portion of pro—brain natriuretic peptide (Pro
- Yu CM, Sanderson JE, Shum IO, et al. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. Eur Heart J 1996- 17:1694−702.
- Tugcu A, Yildirimturk O, Aytekin S. The diagnostic value of N-terminal B-type natriuretic peptide in diastolic heart failure: comparison with echocardiographic findings. Turk Kardiyol Dern Ars. 2009- 37(2): 112−21.
- Kazanegra R, Cheng V, Garcia A, et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study. J Card Fail. 2001−7:21−9.
- Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation. 2002- 105(5):595−601.
- Krishnaswamy P., Lubien E., Clopton P., et al. Utility of B-natriuretic pepetide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 2001- 111:274—9.
- Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 1998−135:825−32.
- Forfia PR, Watkins SP, Rame JE, Stewart KJ, Shapiro EP. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J Am Coll Cardiol. 2005−45:1667−71.
- Joung B., Ha J., Ko Y., et al. Can pro-brain natriuretic peptide be used as a noninvasive predictor of elevated left ventricular diastolic pressures in patients with normal systolic function? Am Heart J 2005- 150:1213—9.
- Dokainish H. Combining tissue Doppler echocardiography and B-type natriuretic peptide in the evaluation of left ventricular filling pressures: review of the literature and clinical recommendations. Can J Cardiol. 2007- 23(12):983−9.
- Redfield M., Rodeheflfer R., Jacobsen S., et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002- 40:976—82.
- Tsutamoto T., Wada A., Sakai H., et al. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol 2006- 47:582—6.
- Wang T., Larson M., Levy D., et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004- 109:594—600.
- Sutton TM, Stewart RA, Gerber IL, et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol. 2003- 41:2280−7.
- Nishikumi T., Matsuoka H. Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure. Circulation 2004- 109: e325—6.
- Mehra M., Uber A., Walther D., et al. Gene expression profiles and B-type natriuretic peptide elevation in heart transplantation: more than a hemodynamic marker. Circulation 2006- 114(1 Suppl):I21—6.
- Kitzman D., Little W., Brubaker H., et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002- 288:2144—50.
- Bursi F., Weston S., Redfield M., et al. Systolic and diastolic heart failure in the community. JAMA 2006- 296:2209—16.
- Мак GS, DeMaria A, Clopton Р, Maisel AS. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: Comparison with tissue Doppler imaging recordings. Am Heart J. 2004−148:895−902
- Abhayaratna WP, Seward JB, Appleton CP, et al. Left atrial size: Physiologic determinants and clinical applications. J Am Coll Cardiol. 2006−47:2357−63.
- Senni M., Tribouilloy C.M.- Rodeheffer R.J. et al. Congestive Heart Failure in the Community. A Study of All Incident Cases in Olmsted County, Minnesota, in 1991 Circulation. 1998- 98 (21):2282−2289.
- Cowie M., Wood D., Coats A., et al. Incidence and aetiology of heart failure. A popylation-based study. Eur Heart J 1999−20:421−28.
- Inouye 1., Massie В., Loge D., et al. Abnormal left ventricular filling: Early findings in mild to moderate systemic hypertension. Am J Cardiol 1984- 53:120—6.
- Lorell BH, Grossman W. Cardiac hypertrophy: the consequences for diastoleJ Am Coll Cardiol. 1987 May- 9(5): 1189−93.
- Chakko S, Woska D, Martinez H, et al. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med 1991- 90:353−359.
- Packer M. Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure. Circulation. 1990- 81(2 Suppl):78−86.
- Kitzman D., Higginbotham M., Cobb F., et al. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991- 17:1065—72.
- Cuocolo A., Sax F., Brush J., et al. Left ventricular hypertrophy and impaired diastolic filling in essential hypertension: diastolic mechanisms for systolic dysfunction during exercise. Circulation 1990- 81:978—86.
- Little W., Downes T. Clinical evaluation of left ventricular diastolic performance. Prog Cardiovasc Dis 1990−32:273−90.
- Hamdani N., PaulusW. Treatment of heart failure with normal ejection fraction. Curr Treat Options Cardiovasc Med. 201 l-13(l):26−34
- Беленков Ю.Н., Мареев В. Ю., Агеев Ф. Т. Хроническая сердечная недостаточность. Избранные лекции по кардиологии.- М.: ГЭОТАР-Медиа, 2006: 248−274.
- Johnston G.D., Hiatt W.R., Nies A.S., et al. Factors modifying the early nondiuretic vascular effects of furo-semide in man. The possible role of renal prostaglandins. Circ.Res., 1983,53:630−635
- Steimle AE, Stevenson LW, Chelimsky-Fallick C, et al. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation. 1997- 96(4):1165−72.
- Nelson GI, Silke B, Ahuja RC, et al. Hemodynamic trial of sequential treatment with diuretic, vasodilator, and positive inotropic drugs in left ventricular failure following acute myocardial infarction. Am Heart J. 1984- 107(6): 1202−9.
- Faris R, Flather MD, Purcell H, Poole-Wilson PA, Coats AJ. Diuretics for heart failure. Cochrane Database Syst Rev. 2006-(1):CD003838
- Преображенский Д.В., Некрасова Н. И., Талызина И. В., Патарая С. А. Торасемид петлевой диуретик нового поколения: особенности фармакологии и клиническая эффективность при сердечной недостаточности. Сердечная недостаточность. 2010. Т. 11, № 5- 294−300.
- Friedel Н., Buckley М. Torasemide. A review of its pharmacological properties and therapeutic potential Drugs, 1991,41 (1), 81−103
- Bolke Т., Achhammer I. Torasemide: review of its pharmacology and therapeutic use. Drugs of Today, 1994,30(8), 1−28
- Yamato M., Sasaki Т., Honda K., et al. Effects of torasemide on left ventricular function and neurohumoral factors m patients with chronic heart failure Circ J, 2003- 67 (5), 384−390.
- Mizuno Y, Yoshimura M, Yasue H, et al. Aldosterone production is activated in failing ventricle in humans. Circulation. 2001- 103(l):72−7.
- Cosin J., Diez J. Torasemide in chronic heart failure: results of the TORIC study Eur J Heart Fail, 2002- 4 (4), 507−513.
- Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999−341 (10):709—717.
- Laviades C., Varo N., Fernandez J., et al. Abnormalities of the extracellular degradation of collagen type I in essential hypertension, Circulation 1998- 98:535—40.
- Nagueh S., Rao L., Soto J., et al. Haemodynamic insights into effects of ischaemia and cycle length on tissue Doppler-derived mitral annulus diastolic velocities. Clin Sci (Lond) 2004- 106:147—54.
- Oh JK, Seward JB, Tajik AJ.: The Echo Manual. 3rd ed. Philadelphia, Lippincott Williams & Wilkins, 2006.
- Yamada H., et al. Prevalence of left ventricular diastolic dysfunction by Doppler echocardiography: clinical application of the Canadian consensus guidelines. J Am Soc Echocardiogr 2002- 15:1238—44.
- Garcia M., Thomas J., Klein A. New Doppler echocardiography applications for the study of diastolic function. J Am Coll Cardiol 1998- 32:865—75.
- Kodama S., Iwata K., Iwata H., et al. Rapid one-step sandwich enzyme immuboassay for tissue inhibitor of metalloproteinases: an application for rheumatoid arthritis serum and plasma. J Immunol Methods 1990−127:103−8.
- Meikko J., Niemi S., Risteli L. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 1990−36:1328−32.
- Risteli J., Elomaa I., Niemi S., et al. Radioimmunoassay for the pyridinoine cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993- 39:635—40.
- Levin E., Gardner D., Samson W. Natriuretic peptides. N Engl Med 1998−339:321−8.
- Valli N., Gobinet A., Bordenave L. Review of 10 years of the clinical use of brain natriuretic peptide in cardiology. J Lab Clin Med 1999- 134:43714.
- Weber KT. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol. 1989- 13(7): 1637−52.
- Lesne M. Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers, Arzheim Frosch Drug Res 38 (1988), 160−163.
- Tschope C., Kasner M., Westermann D., et al. The role ofNT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Herat J 2005- 26:2277—84.
- Vasan R., Benjamin E., Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J. Am Coll Cardiol 1995- 26:1565—74.
- Devereux RB, Roman MJ, Liu JE, et al. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am J Cardiol. 2000 Nov 15- 86(10): 1090−6.
- Weber K., Anversa P., Armstrong P., et al. Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol 1992−20:3−16.
- Barasch e, Gotdiener JS, Aurigemma G et al. Myocardial matrix remodeling and the matrix metalloproteinases: infuence on cardiac form and function. Physiol Rev. 2007−87 (4): 1285−1 342 188 189 190 191 214 762 730 742 570 349 526 185 060 855 709 696
- Oki Т., Tabata Т., Yamada H., et al. Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricular relaxation. Am J Cardiol 1997- 79:921—8.
- Mullens W., Borowsky A., Curtin R., at al. Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients patients with advanced systolic heart failure. Circulation 2009- 119:62—70.
- Owan Т., Hodge D., Herges R. et al. Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2006- 355(3):251−259.
- Фомин И.В. Эпидемиология сердечной недостаточности: главные выводы исследования ЭПОХА. Доклад 8 декабря 2006 г. на I Конгрессе Общества специалистов по сердечной недостаточности «Сердечная недостаточность, 2006», 7−9 декабря 2006 г., Москва.
- Sun Y., Zhang J., Lu L., et al. Aldosterone-induced inflammation in the rat heart: Role of oxidative stress. Am J Pathol 2002- 161:1773—81.
- Bloor C., Nimmo L., McKirnan M., et al. Increased gene expression of plasminogen activators and inhibitors in left ventricular hypertrophy. Moll Cell Biochem 1997- 176:265—71.
- Kawano H., Do Y., Kawano Y., et al. Angiotensin II has multiple profibrotic effects in human cardiac fibroblast. Circulation 2000−101:1130—7.
- MUgge A., Schmitz W., Schollz H. Negative inotropic effects of aldosterone antagonists in isolated human and guinea pig ventricular heart muscle. Klin Wochenschr 1984−62:717—23.
- Yoshimura M., Nakamura S., Ito Т., et al. Expression of aldosterone synthase gene in failing human heart: Quantitative analysis using modified real-time polymerase chain reaction. J Clin Endocrinol Metab 2002−87:3936—40.
- Opie L., Kaplan N. Diuretics. In: Opie L., Gersh B. (eds): Drugs for the heart (6th ed). Elsevier Saunders 2005- p.p. 80—103.
- Achhammer 1. Long term efficacy and tolerance of torasemide in congestive heart failure. In: Progress in Pharmacology and Clinical Pharmacology. Ed. By F.M. Eichelbaum et al. vol. 8. № 1. Stuttgart New York. 1990- 127−136.
- Achhammer I, Metz P. Low dose loop diuretics in essential hypertension. Experience with torasemide. Drugs. 1991 -4 (Suppl 3):80−91.
- Baumgart P. Torasemide in comparison with thiazides in the treatment of hypertension. Cardiovasc DrugsTer 1993−7 (Suppl l):63−68.
- Ткачева О.Н., Шарашкина H.B., Новикова И. М., Чухарева H.А.Сравнительное исследование эффектов торасемида и гипотиазида в комбинированном лечении гипертонической болезни у женщин в период постменопаузы. Журнал Сердце.2011.Том 10,№ 3(59): 156−160.
- Laurent G. Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol 1987−251 :C1—9.
- Ala-Kopsala M., Magga J., Peuhkurinen K., et al. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem 2004−50:1576−88.
- O’Neill J., Bott-Silverman C., McRae A. 3rd, et al. B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure. Am Heart J 2005−149:363−9.
- Mukoyama M., Nakao K., Hosoda K., et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991−87:1402−12.
- Rodeheffer R., Tanaka I., Imada T. et al. Atrial pressure and secretion of atrial natriuretic factor into the human central circulation. J Am Coll Cardiol 1986- 8:18—26.
- Thibault G., Amiri F., Garcia R. Regulation of natriuretic peptide secretion by the heart. Annu Rev Physiol 1999−61:193−217.
- Rousseau M., Gurne O., Duprez D. et al. Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy. Am Coll Cardiol 2002- 40(9):1596—1601.
- Latini R., Masson S., Anand I. et al.- for the Val-HeFT Investigators. Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure. Circulation. 2002- 106(19):2454−2458.